Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Chemring hails record order book amid military ramp up

(Sharecast News) - UK defence company Chemring on Tuesday reported a record order book at the half-year stage and held full-year guidance as governments continued to ramp up military spending. Orders at the end of April stood at £1.4bn, a rise of 8%. Underlying core earnings fell 2% to £38.2m.

Underlying operating profit fell to £24.5m from £26.5m a year ago, leading to a decline in operating margin to 10.3% from 11.9%. Revenue rose to 7% £237.3m.

The company, which develops countermeasure systems and explosives, also took an £8.3m impairment charge after closing its alloy surfaces division in the US after a strategic review found it could not secure sufficient orders to sustain operations.

"Elevated defence and national security spending is increasingly seen as a structural feature of the geopolitical environment, rather than a temporary response to current conflicts and regional tensions," Chemring said.

"Across NATO, planning assumptions have shifted towards territorial defence and peer-conflict readiness, supporting structurally higher budgets."

Reporting by Frank Prenesti for Sharecast.com

See latest RNS on Investegate

Share this article

Related Sharecast Articles

Deutsche Bank lifts AB Foods price target after results, maintains 'hold'
(Sharecast News) - Deutsche Bank lifted its price target on Associated British Foods on Monday to 1,820p from 1,790p following the Primark owner's full-year results last week.
Mkango advances Texas facility as company awaits fundraising
(Sharecast News) - Mkango Magnetic Materials announced further progress at its rare earth magnet recycling facility in Texas on Monday, following the delivery of its first major processing equipment, though trading in the company's shares was temporarily suspended amid plans for a fundraising.
RUA Life Sciences shares slump as French arm underperforms
(Sharecast News) - Shares in AIM-listed RUA Life Sciences tumbled on Monday after the medical devices group reported weaker-than-expected trading at its French subsidiary Abiss, despite forecasting higher annual revenues and a return to profitability.
Tuesday preview: Vodafone, CoreWeave results due; Chinese trade figures in focus
(Sharecast News) - On Tuesday, investors will eye first-half results from Vodafone, Oxford Instruments and DCC Energy, and trading updates from Watches of Switzerland and Princes Group.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.